Smith+Nephew (LSE:SN.) has announced that Chief Financial Officer John Rogers will step down from his role on September 30 to take up an external opportunity in the United States.
Rogers has already resigned from the company’s Board with immediate effect, while Smith+Nephew has started the process of identifying a permanent successor.
Rogers Departs After Three Years as CFO
Rogers has served as Chief Financial Officer for the past three years, a period that included the delivery of Smith+Nephew’s 12-Point Plan, improvements in the medical technology group’s financial performance and the development of its RISE strategy.
Chief Executive Officer Deepak Nath thanked Rogers for his contribution to the business, saying: “I would like to thank John for his many contributions over the last three years as we’ve delivered the 12-Point Plan, improved our financial performance and developed the RISE strategy. He has been a valued colleague and a highly regarded member of our Executive Committee.”
Rogers will remain in his CFO position until the end of September, providing a transition period before his departure for the new U.S.-based role.
Pierre Palassian Named Interim CFO
Smith+Nephew has appointed Pierre Palassian, currently Senior Vice President Finance and Group Controller, as interim Chief Financial Officer until a permanent replacement is selected.
Palassian brings more than 20 years of financial leadership experience and has previously overseen finance functions across several areas of Smith+Nephew’s operations. These include Global Operations, R&D, Advanced Wound Management, Sports Medicine, International Markets and Emerging Markets.
He joined Smith+Nephew in June 2017 after previously holding senior positions at Abbvie and Abbott Laboratories. His extensive experience within the group should provide continuity while the company conducts its search for a new permanent CFO.
Leave a Reply